bioRxivPharmacology & ToxicologyPreprint
A Degron Decoy System Co-opts Pathological Seeding to Enable Clearance of Multimeric α-Synuclein.
Gillian E. GadboisiD, Alexander P. PlonskiiD, Galia T. DebelouchinaiD, Fleur M. FergusoniD
Abstract
Pathological seeding of protein misfolding is a hallmark of proteinopathies. However therapeutic strategies to clear these aggregates are lacking, impairing both study of their biological importance in disease etiology and progression as well as development of therapeutics. This is due in part to the need to selectively clear oligomerized proteins whilst leaving functional monomers intact, as well as the challenge of developing molecules that act on the full complement of misfolds the protein can adopt throughout the course of disease. In this work, we describe a dopant system consisting of an engineered alpha-synuclein protein construct that rapidly co-aggregates into existing WT alpha-synuclein oligomers, enabling rapid degradation of the entire assembly in the presence of a small molecule trigger. This work provides proof-of-principle for an approach that transforms pathological seeding from a disease-driver into a therapeutic vulnerability, and is potentially applicable to any proteinopathy without requiring a small molecule binder of the pathologic species.
- assay: protein structure
- research focus: protein folding & dynamics
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeted degradation of α-synuclein prevents PFF-induced aggregation
Bill Carton, Géraldine Gelders, … Gopal P. Sapkota·bioRxiv·Apr 15, 2025
- Leveraging Supramolecular Polymers to Induce the Targeted Protein Degradation of α-Synuclein
Windfield S. Swetman, Malay Mondal, … Tristan D. Clemons·bioRxiv·Jul 23, 2026
- Characterization of pathology-inducing α-synuclein species from human diseased brain tissue
John D. Graef, Nina Hoque, … Jere E. Meredith·bioRxiv·Mar 25, 2019
- Single-Domain Antibody-Based Protein Degrader for Synucleinopathies
Yixiang Jiang, Yan Lin, … Einar M. Sigurdsson·bioRxiv·Mar 11, 2024
- Structure-function relationship of alpha-synuclein fibrillar polymorphs derived from distinct synucleinopathies
Tetiana Serdiuk, Virginie Redeker, … Paola Picotti·Molecular Systems BiologyPeer-reviewed·Mar 11, 2026
- A Facile Method to Produce N-Terminally Truncated α-Synuclein
R. J. Thrush, D. M. Vadukul, F. A. Aprile·bioRxiv·Feb 21, 2022